Jack U'ren

Jack U'ren is a notable inventor based in Kirkland, WA (US). He has made significant contributions to the fields of medical diagnostics and molecular biology. With a total of 3 patents, U'ren's work focuses on innovative methods for detecting genetic predispositions and analyzing nucleic acids.

Latest Patents

U'ren's latest patents include groundbreaking technologies. One patent is titled "Compositions and methods for determining predisposition to insulin dependent diabetes mellitus." This invention outlines methods for detecting the presence of HLA DQB1 alleles 0201/0202, 0302/0303, and/or 0602 in human biological samples, which are associated with susceptibility to insulin dependent diabetes mellitus. Another significant patent is the "Universal solid-phase hybridization apparatus." This method involves determining the presence of a nucleic acid analyte from a sample by binding a biotinylated capture oligonucleotide to a solid phase non-covalently coated with streptavidin or an avidin derivative.

Career Highlights

Jack U'ren is currently associated with Saigene Corporation, where he continues to innovate in the field of biotechnology. His work has been instrumental in advancing diagnostic methods that can lead to better health outcomes for individuals at risk of diabetes.

Collaborations

U'ren has collaborated with notable colleagues, including Sharon Howard and Vivian H Gersuk. These partnerships have contributed to the development of his innovative technologies and have enhanced the impact of his work in the scientific community.

Conclusion

Jack U'ren's contributions to medical diagnostics and molecular biology are noteworthy. His patents reflect a commitment to improving health through innovative technologies. U'ren's work continues to influence the fields of diabetes detection and nucleic acid analysis.